Government of United Kingdom   Report issue

Government Phase 2 Phase 3 Phase 4
Founded: London United Kingdom (1215)

Organization Overview

First Clinical Trial
2012
NCT01618591
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Army Health and Performance Research, Andover, UK | Army Health Branch, British Army | Department for International Development, United Kingdom | Economic and Social Research Council, United Kingdom | Institute of Naval Medicine | Ministry of Defence, United Kingdom | National Cancer Imaging Translational Accelerator | National Institute for Health Research Leicester Biomedical Research Centre, Leicester, UK | Navy Command Headquarters | Public Health Agency (Northern Ireland) | Royal Centre for Defence Medicine | Royal Centre of Defence Medicine, Birmingham, UK | UK Department of Health | UK Research and Innovation | United Kingdom Department for International Development | Welsh Government

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 3)

Fever (Phase 4)

Fractures, Bone (Phase 3)

Fractures, Stress (Phase 3)

Malaria (Phase 4)

Malaria, Falciparum (Phase 4)

Neuroblastoma (Phase 2)

Pneumonia (Phase 3)

Severe Acute Respiratory Syndrome (Phase 3)

Typhoid Fever (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 18
  • # of Trial APIs: 29